23 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
4
Discovery of furan carboxylate derivatives as novel inhibitors of ATP-citrate lyase via virtual high-throughput screening.

Harvard Medical School
15
Design and synthesis of emodin derivatives as novel inhibitors of ATP-citrate lyase.

Harvard Medical School
36
The lipogenesis pathway as a cancer target.

Wayne State University
13
The biology and chemistry of hyperlipidemia.

Sinhgad College of Pharmacy
3
ATP-citrate lyase as a target for hypolipidemic intervention. Sulfoximine and 3-hydroxy-beta-lactam containing analogues of citric acid as potential tight-binding inhibitors.

Smithkline Beecham Pharmaceuticals
2
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia.

University of Cambridge
3
NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family.

Johann Wolfgang Goethe University
15
Macrocyclization strategy for improving candidate profiles in medicinal chemistry.

Gachon University
13
2-hydroxy-N-arylbenzenesulfonamides as ATP-citrate lyase inhibitors.

Bristol Myers Squibb
24
Opportunities and Challenges for Inhibitors Targeting Citrate Transport and Metabolism in Drug Discovery.

China Pharmaceutical University
7
Structurally Diverse Triterpene-26-oic Acids as Potential Dual ACL and ACC1 Inhibitors from the Vulnerable Conifer

Fudan University
13
Forrestiacids E-K: Further [4 + 2]-Type Triterpene-Diterpene Hybrids as Potential ACL Inhibitors from the Vulnerable Conifer

Taizhou University
4
Cinerols, Nitrogenous Meroterpenoids from the Marine Sponge

Shanghai Jiao Tong University
34
ATP-Citrate lyase as a target for hypolipidemic intervention. 2. Synthesis and evaluation of (3R,5S)-omega-substituted-3-carboxy-3, 5-dihydroxyalkanoic acids and their gamma-lactone prodrugs as inhibitors of the enzyme in vitro and in vivo.

Smithkline Beecham Pharmaceuticals
54
ATP-citrate lyase as a target for hypolipidemic intervention. Design and synthesis of 2-substituted butanedioic acids as novel, potent inhibitors of the enzyme.

Smithkline Beecham Pharmaceuticals
13
Synthesis of novel thiol-containing citric acid analogues. Kinetic evaluation of these and other potential active-site-directed and mechanism-based inhibitors of ATP citrate lyase.

Smithkline Beecham Pharmaceuticals
23
ATP citrate lyase (ACLY) inhibitors: An anti-cancer strategy at the crossroads of glucose and lipid metabolism.

University of Pisa
6
Synthesis and hypolipidemic and antidiabetogenic activities of beta,beta,beta',beta'-tetrasubstituted, long-chain dioic acids.

Hebrew University
5
EGFR Inhibitors in cancer treatment

Celyn Therapeutics
62
Compound as protein kinase inhibitor, and pharmaceutical composition comprising thereof

Hk Inno.N
5
NUCLEAR TRANSPORT MODULATORS AND USES THEREOF

Karyopharm Therapeutics
42
SEROTONIN 5-HT2A, 5-HT2B, AND 5-HT2C RECEPTOR INVERSE AGONISTS

Northeastern University
225
OX2R compounds

University ff Texas System